Published in CA Cancer J Clin on August 14, 2009
Cancer Pain: A Critical Review of Mechanism-based Classification and Physical Therapy Management in Palliative Care. Indian J Palliat Care (2011) 1.14
Mechanism-based Classification and Physical Therapy Management of Persons with Cancer Pain: A Prospective Case Series. Indian J Palliat Care (2013) 0.91
Effectiveness of a clinical intervention to eliminate barriers to pain and fatigue management in oncology. J Palliat Med (2011) 0.85
Cancer pain management in resource-limited settings: a practice review. Pain Res Treat (2011) 0.82
Randomized Controlled Trial in Advance Stage Breast Cancer Patients for the Effectiveness on Stress Marker and Pain through Sudarshan Kriya and Pranayam. Indian J Palliat Care (2013) 0.82
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27
Early specialty palliative care--translating data in oncology into practice. N Engl J Med (2013) 3.58
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat (2002) 3.19
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76
American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol (2009) 2.12
Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. Oncology (Williston Park) (2014) 2.06
Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin (2015) 1.97
Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2014) 1.95
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol (2008) 1.93
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin (2013) 1.75
Palliative care and the quality of life. J Clin Oncol (2011) 1.75
Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst (2002) 1.44
High prevalence of triple-negative tumors in an urban cancer center. Cancer (2008) 1.43
Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004. Urology (2005) 1.42
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38
Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer (2008) 1.36
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol (2008) 1.28
Reducing the toxicity of cancer therapy: recognizing needs, taking action. Nat Rev Clin Oncol (2012) 1.27
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev (2012) 1.14
Racial disparities in colorectal cancer. Curr Probl Cancer (2007) 1.11
From the guest editors: introduction for the impact of health care reform on cancer patients. Cancer J (2010) 1.08
Colorectal carcinoma in black and white race. Cancer Metastasis Rev (2003) 1.07
Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin (2009) 1.05
Prostate cancer in black and white Americans. Cancer Metastasis Rev (2003) 1.05
Myeloma and race: a review of the literature. Cancer Metastasis Rev (2003) 1.00
The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin (2010) 1.00
Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. Cancer (2010) 0.99
Introducing the 2010 American Cancer Society prostate cancer screening guideline. CA Cancer J Clin (2010) 0.99
Risk-based mammography screening: an effort to maximize the benefits and minimize the harms. Ann Intern Med (2012) 0.98
Is race really a negative prognostic factor for cancer? J Natl Cancer Inst (2009) 0.97
The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol (2004) 0.97
Racial disparities in lung cancer. Curr Probl Cancer (2007) 0.96
NIH consensus development statement on hydroxyurea treatment for sickle cell disease. NIH Consens State Sci Statements (2008) 0.95
Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma (2013) 0.95
A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer (2010) 0.93
Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer (2009) 0.90
Avoidable cancer deaths globally. CA Cancer J Clin (2011) 0.90
Some perspective on black-white cancer statistics. CA Cancer J Clin (2002) 0.89
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res (2013) 0.89
Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer (2007) 0.88
Informed consent for prostate-specific antigen-based screening. Urology (2003) 0.84
A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.84
Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment. J Clin Oncol (2005) 0.82
Health care policy and cancer survivorship. Cancer (2013) 0.82
CDC Grand Rounds: the future of cancer screening. MMWR Morb Mortal Wkly Rep (2015) 0.82
Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psychooncology (2011) 0.81
Prostate cancer screening; is this a teachable moment? J Natl Cancer Inst (2009) 0.81
The National Breast and Cervical Cancer Early Detection Program: toward a system of cancer screening in the United States. Cancer (2014) 0.80
The potential for prostate cancer chemoprevention. Rev Urol (2002) 0.77
Phase III prostate cancer chemoprevention trials. Recent Results Cancer Res (2014) 0.75
Oophorectomy in carriers of BRCA mutations. N Engl J Med (2002) 0.75
A brief history of the American Cancer Society Extramural Research Program. CA Cancer J Clin (2012) 0.75
Curbing tobacco's toll starts with the professionals: World No Tobacco Day. Lancet (2005) 0.75
The argument for breast cancer screening. Clin Adv Hematol Oncol (2014) 0.75
Information over exaggeration. US News World Rep (2009) 0.75
Reviewer acknowledgment 2015. CA Cancer J Clin (2015) 0.75
Pediatric research: the role of the institutional review board. Mo Med (2002) 0.75
Chemoprevention in prostate cancer. Curr Probl Cancer (2004) 0.75
New ACS chief medical officer. Interview by Carrie Printz. Cancer (2008) 0.75